OBJECTIVE: To determine whether periodontitis is associated with human papillomavirus (HPV) status of head and neck squamous cell carcinoma (HNSCC). DESIGN AND SETTING: Hospital-based case-control study in a comprehensive cancer center. PATIENTS: Evaluation included all patients diagnosed with incident primary squamous cell carcinoma of the oral cavity, oropharynx, and larynx between 1999 and 2007 for whom tissue samples and dental records were available (N = 124). Patients younger than 21 years and those with a history of cancer were excluded. Periodontitis history was assessed by alveolar bone loss in millimeters from panoramic radiographs by one examiner blinded to cancer status. MAIN OUTCOME MEASURE: The presence of HPV-16 DNA in paraffin-embedded tumor samples was identified by polymerase chain reaction. RESULTS: The prevalence of HPV-positive HNSCC was 50 of 124 patients (40.3%). A higher proportion of oropharyngeal cancers were HPV-positive (32 of 49 [65.3%]) compared with oral cavity (9 of 31 [29.0%]) and laryngeal (9 of 44 [20.5%]) cancers. Each millimeter of alveolar bone loss was associated with 2.6 times increased odds (odds ratio [OR], 2.61; 95% CI, 1.58-4.30) of HPV-positive tumor status after adjustment for age at diagnosis, sex, and smoking status. The strength of the association was greater among patients with oropharyngeal SCC (OR, 11.70; 95% CI, 2.09-65.53) compared with those with oral cavity SCC (OR, 2.32; 95% CI, 0.65-8.27) and laryngeal SCC (OR, 3.89; 95% CI, 0.95-15.99). CONCLUSIONS: A history of chronic inflammatory disease in the oral cavity may be associated with tumor HPV status in patients with HNSCC. This association seems to be stronger among patients with oropharyngeal cancer compared with those who have oral cavity or laryngeal SCC.
OBJECTIVE: To determine whether periodontitis is associated with human papillomavirus (HPV) status of head and neck squamous cell carcinoma (HNSCC). DESIGN AND SETTING: Hospital-based case-control study in a comprehensive cancer center. PATIENTS: Evaluation included all patients diagnosed with incident primary squamous cell carcinoma of the oral cavity, oropharynx, and larynx between 1999 and 2007 for whom tissue samples and dental records were available (N = 124). Patients younger than 21 years and those with a history of cancer were excluded. Periodontitis history was assessed by alveolar bone loss in millimeters from panoramic radiographs by one examiner blinded to cancer status. MAIN OUTCOME MEASURE: The presence of HPV-16 DNA in paraffin-embedded tumor samples was identified by polymerase chain reaction. RESULTS: The prevalence of HPV-positive HNSCC was 50 of 124 patients (40.3%). A higher proportion of oropharyngeal cancers were HPV-positive (32 of 49 [65.3%]) compared with oral cavity (9 of 31 [29.0%]) and laryngeal (9 of 44 [20.5%]) cancers. Each millimeter of alveolar bone loss was associated with 2.6 times increased odds (odds ratio [OR], 2.61; 95% CI, 1.58-4.30) of HPV-positive tumor status after adjustment for age at diagnosis, sex, and smoking status. The strength of the association was greater among patients with oropharyngeal SCC (OR, 11.70; 95% CI, 2.09-65.53) compared with those with oral cavity SCC (OR, 2.32; 95% CI, 0.65-8.27) and laryngeal SCC (OR, 3.89; 95% CI, 0.95-15.99). CONCLUSIONS: A history of chronic inflammatory disease in the oral cavity may be associated with tumor HPV status in patients with HNSCC. This association seems to be stronger among patients with oropharyngeal cancer compared with those who have oral cavity or laryngeal SCC.
Authors: P E Castle; S L Hillier; L K Rabe; A Hildesheim; R Herrero; M C Bratti; M E Sherman; R D Burk; A C Rodriguez; M Alfaro; M L Hutchinson; J Morales; M Schiffman Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-10 Impact factor: 4.254
Authors: Mine Tezal; Maureen Sullivan Nasca; Daniel L Stoler; Thomas Melendy; Andrew Hyland; Philip J Smaldino; Nestor R Rigual; Thom R Loree Journal: Arch Otolaryngol Head Neck Surg Date: 2009-04
Authors: Joel A Ernster; Cosimo G Sciotto; Maureen M O'Brien; Jack L Finch; Linda J Robinson; Thomas Willson; Michael Mathews Journal: Laryngoscope Date: 2007-12 Impact factor: 3.325
Authors: Elisabeth G Vichaya; Jessica M Molkentine; Daniel W Vermeer; Adam K Walker; Rebekah Feng; Gerard Holder; Katherine Luu; Ryan M Mason; Leo Saligan; Cobi J Heijnen; Annemieke Kavelaars; Kathy A Mason; John H Lee; Robert Dantzer Journal: Behav Brain Res Date: 2015-10-22 Impact factor: 3.332
Authors: Margaret Rosario; Heather L Corliss; Bethany G Everett; Stephen T Russell; Francisco O Buchting; Michelle A Birkett Journal: Am J Public Health Date: 2014-04-17 Impact factor: 9.308
Authors: Nitin Shivappa; James R Hébert; Valentina Rosato; Werner Garavello; Diego Serraino; Carlo La Vecchia Journal: Int J Cancer Date: 2017-05-09 Impact factor: 7.396
Authors: Angela L Mazul; James M Taylor; Kimon Divaris; Mark C Weissler; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Andrew F Olshan; Jose P Zevallos Journal: Cancer Date: 2016-08-29 Impact factor: 6.860
Authors: Mahnaz Fatahzadeh; Nicolas F Schlecht; Zigui Chen; Danielle Bottalico; Sharod McKinney; Janae Ostoloza; Anne Dunne; Robert D Burk Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2013-01-31